Image Trademark of Smithkline Beecham Corporation Trademark Details
Status | Dead 606 — Abandoned - No Statement of Use Filed |
---|
Current Owner
Smithkline Beecham Corporation of Philadelphia, PA
View all trademarks for Smithkline Beecham CorporationSerial Number | 78426879 |
---|---|
Status Date | Friday, October 5, 2007 |
Filing Date | Friday, October 5, 2007 |
Attorney | Terence A. Dixon |
Correspondent
Terence A. Dixon
GlaxoSmithKline
UW2221
709 Swedeland Road
King of Prussia PA 19406
GlaxoSmithKline
UW2221
709 Swedeland Road
King of Prussia PA 19406
Case File Statements
Description of Mark | The mark consists of an "X" design in the form of a figure with a circle for the head. |
---|---|
Goods & Services | Pharmaceutical preparations, namely, weight control preparations |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Thursday, June 3, 2004 |
Primary Code | 005 |
Trademark Timeline
-
May 28 2004Trademark application filed with USPTO
-
Jun 03 2004New Application Entered In Tram
-
Jan 03 2005Approved For Pub - Principal Register
-
Jan 03 2005Assigned To Examiner
-
Jan 07 2005Assigned To Lie
-
Jan 08 2005Law Office Publication Review Completed
-
Jan 10 2005Assigned To Lie
-
Jun 22 2005Notice of Publication
-
Jul 12 2005Published For Opposition
-
Oct 04 2005Noa Mailed - Sou Required From Applicant
-
Dec 20 2005Assigned To Examiner
-
Mar 31 2006Extension 1 Granted
-
Mar 31 2006Extension 1 Filed
-
Mar 31 2006Teas Extension Received
-
Sep 12 2006Extension 2 Granted
-
Sep 12 2006Extension 2 Filed
-
Sep 12 2006Teas Extension Received
-
Nov 28 2006Attorney Revoked And/or Appointed
-
Nov 28 2006Teas Revoke/appoint Attorney Received
-
Feb 19 2007Attorney Revoked And/or Appointed
-
Feb 19 2007Teas Revoke/appoint Attorney Received
-
Mar 05 2007Extension 3 Granted
-
Mar 05 2007Extension 3 Filed
-
Mar 05 2007Teas Extension Received
-
Dec 12 2007Abandonment - No Use Statement Filed
-
Dec 13 2007Abandonment Notice Mailed - No Use Statement Filed